ProShare Advisors’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-13,716
Closed -$727K 2112
2024
Q2
$727K Sell
13,716
-4,686
-25% -$307K ﹤0.01% 821
2024
Q1
$1.51M Buy
18,402
+2,487
+16% +$111K ﹤0.01% 708
2023
Q4
$296K Buy
15,915
+3,424
+27% +$44.8K ﹤0.01% 1392
2023
Q3
$138K Sell
12,491
-14
-0.1% -$200 ﹤0.01% 1568
2023
Q2
$203K Buy
+12,505
New +$262K ﹤0.01% 1533
2022
Q2
Sell
-12,825
Closed -$39K 2140
2022
Q1
$39K Sell
12,825
-2,122
-14% -$7.61K ﹤0.01% 2130
2021
Q4
$69K Buy
+14,947
New +$83.8K ﹤0.01% 2245
2021
Q3
Sell
-17,747
Closed -$106K 2279
2021
Q2
$106K Buy
17,747
+223
+1% +$1.32K ﹤0.01% 2284
2021
Q1
$111K Buy
17,524
+2,998
+21% +$21.1K ﹤0.01% 2153
2020
Q4
$82K Buy
+14,526
New +$88K ﹤0.01% 2012

Other funds holding VKTX